Yi Hong Yao

Chief Tech/Sci/R&D Officer at CELLULAR BIOMEDICINE GROUP, INC.

59 year

Consumer Services

Health Technology

Profile

Yi Hong Yao is currently Chief Scientific Officer at AbelZeta Pharma, Inc. since 2015.
Formerly, Dr. Yao was Director at MedImmune LLC from 2011 to 2015.
Education includes graduate studies at Boston University, a doctorate from the University of Kansas, and undergraduate studies at Fudan University.

Yi Hong Yao active positions

Companies	Position	Start
CELLULAR BIOMEDICINE GROUP, INC.	Chief Tech/Sci/R&D Officer	01/08/2015

All active positions of Yi Hong Yao

Former positions of Yi Hong Yao

Companies	Position	End
MedImmune LLC MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company	Director/Board Member	01/07/2015

See the detail of Yi Hong Yao's experience

Training of Yi Hong Yao

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Yi Hong Yao's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
MedImmune LLC MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company	Health Technology
Boston University Boston University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Kansas University of Kansas Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Fudan University Fudan University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
AbelZeta Pharma, Inc. AbelZeta Pharma, Inc. BiotechnologyHealth Technology Develops cell therapies to cure cancer and inflammatory & immunological diseases	Health Technology